These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17476196)

  • 81. Neurophysiologic and intellectual evaluation of beta-thalassemia patients.
    Economou M; Zafeiriou DI; Kontopoulos E; Gompakis N; Koussi A; Perifanis V; Athanassiou-Metaxa M
    Brain Dev; 2006 Jan; 28(1):14-8. PubMed ID: 15925466
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Audiological evaluation in adult beta-thalassemia major patients under regular chelation treatment.
    Ambrosetti U; Dondè E; Piatti G; Cappellini MD
    Pharmacol Res; 2000 Nov; 42(5):485-7. PubMed ID: 11023713
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Elevated Prevalence of Abnormal Glucose Metabolism and Other Endocrine Disorders in Patients with β-Thalassemia Major: A Meta-Analysis.
    He LN; Chen W; Yang Y; Xie YJ; Xiong ZY; Chen DY; Lu D; Liu NQ; Yang YH; Sun XF
    Biomed Res Int; 2019; 2019():6573497. PubMed ID: 31119181
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Yersinia enterocolitica ileocolitis in beta-thalassemic patients.
    Greco L; Marino F; Gentile A; Catalano G; Angilletta D
    Colorectal Dis; 2006 Jul; 8(6):525. PubMed ID: 16784477
    [No Abstract]   [Full Text] [Related]  

  • 85. The evolution of glucose-insulin homeostasis in children with β-thalassemia major (β -TM): A twenty-year retrospective ICET- A observational analysis from early childhood to young adulthood.
    De Sanctis V; Daar S; Soliman AT; Tzoulis P; Karimi M; Kattamis C
    Acta Biomed; 2022 Jul; 93(3):e2022243. PubMed ID: 35775765
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Combined chelation therapy improves glucose metabolism in patients with beta-thalassaemia major.
    Christoforidis A; Perifanis V; Athanassiou-Metaxa M
    Br J Haematol; 2006 Oct; 135(2):271-2. PubMed ID: 16965387
    [No Abstract]   [Full Text] [Related]  

  • 87. The effect of curcumin on serum copper, zinc, and zinc/copper ratio in patients with β-thalassemia intermedia: a randomized double-blind clinical trial.
    Saeidnia M; Nowrouzi-Sohrabi P; Erfani M; Fazeli P; Tamaddon G; Karimi M
    Ann Hematol; 2021 Mar; 100(3):627-633. PubMed ID: 33432439
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Alpha and beta cell evaluation in patients with thalassaemia intermedia and iron overload.
    De Sanctis V; Gamberini MR; Borgatti L; Atti G; Vullo C; Bagni B
    Postgrad Med J; 1985 Nov; 61(721):963-7. PubMed ID: 3906615
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A Cross-Sectional Study of Glycemic Status and Zinc Level in Patients with Beta-Thalassemia Major.
    Mashhadi MA; Sepehri Z; Heidari Z; Kaykhaei MA; Sargazi A; Kohan F; Heidari H
    Int J Hematol Oncol Stem Cell Res; 2017 Oct; 11(4):273-280. PubMed ID: 29340122
    [No Abstract]   [Full Text] [Related]  

  • 90. [Zinc concentration in serum and saliva of patients during heavy metal chelating therapy].
    Gerhardt H; Matthes KJ
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():407-9. PubMed ID: 611991
    [No Abstract]   [Full Text] [Related]  

  • 91. Glucose tolerance, plasma and pancreatic insulin levels in zinc deficient rats.
    Brown ED; Penhos JC; Recant L; Smith JC
    Proc Soc Exp Biol Med; 1975 Dec; 150(3):557-60. PubMed ID: 1208574
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The different patterns of insulin response during Oral Glucose Tolerance Test (OGTT) in transfused young patients with β-Thalassemia.
    Kattamis C; Ladis V; Skafida M; Iacovidou N; Theodoridis C
    Acta Biomed; 2021 Sep; 92(4):e2021265. PubMed ID: 34487086
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Neurophysiologic study of beta-thalassemia patients.
    Wong V; Li A; Lee AC
    J Child Neurol; 1993 Oct; 8(4):330-5. PubMed ID: 8228027
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effects of Zinc Deficiency in Male Mice on Glucose Metabolism of Male Offspring.
    Li Y; Li L; Yang W; Yu Z
    Chem Pharm Bull (Tokyo); 2022 May; 70(5):369-374. PubMed ID: 35228455
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Insulin resistance, impaired glucose tolerance and alpha-thalassemia carrier state.
    Bahar A; Shekarriz R; Janbabai G; Shirzad R; Aarabi M; Kashi Z
    J Diabetes Metab Disord; 2015; 14():2. PubMed ID: 25722965
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Risk factors for death in patients with beta-thalassemia major: results of a case-control study.
    Ceci A; Baiardi P; Catapano M; Felisi M; Cianciulli P; De Sanctis V; Del Vecchio GC; Magnano C; Meo A; Maggio A
    Haematologica; 2006 Oct; 91(10):1420-1. PubMed ID: 16963395
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Gradient-echo magnetic resonance imaging study of pancreatic iron overload in young Egyptian beta-thalassemia major patients and effect of splenectomy.
    Matter RM; Allam KE; Sadony AM
    Diabetol Metab Syndr; 2010 Apr; 2():23. PubMed ID: 20398341
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Addison's disease and the regulation of potassium: the role of insulin and aldosterone.
    Harvey TC
    Med Hypotheses; 2007; 69(5):1120-6. PubMed ID: 17459601
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Adverse effect of antipyretic agent on serum zinc.
    Shoji S; Miyamoto H; Nomoto S
    Ann Clin Lab Sci; 1993; 23(2):106-10. PubMed ID: 8457139
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Major beta-thalassemia, use of desferiexamine and renal proximal tubular damage.
    Jafari HM; Vahidshahi K; Kosaryan M; Karami H; Reza Mahdavi M; Ehteshami S
    Bratisl Lek Listy; 2011; 112(5):278-81. PubMed ID: 21682083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.